The First Marijuana Hearing Of The New Congress Has Been Scheduled

A House subcommittee on crime and drug policy will hold its first marijuana hearing of the new Congress on Monday. Representatives from the Judiciary Committee are expected to take up a comprehensive package to end federal marijuana prohibition and decriminalize marijuana. Rep. Nadler has championed reform of marijuana policies since the 1970s. Meanwhile, Rep. Bass hails from California and has long been an advocate of legalization.

The new congress has set a date for the first marijuana hearing. The bill will give the Department of Health and Human Services the power to decriminalize cannabis. While decriminalizing marijuana is unlikely in the near future, relaxing regulations on research could be the first step towards making it more accessible. This could include relaxing registration requirements, permitting researchers to source cannabis from facilities outside Schedule I facilities, and allowing them to study different strains.

While some lawmakers have been wary of decriminalizing marijuana, Republicans have stepped forward with a proposal that would decriminalize the drug on a federal level. This idea has previously been championed by Democrats high cbd strain seeds and Republicans. South Carolina Republican Rep. Nancy Mace has introduced a bill called the States Reform Act that would regulate cannabis like alcohol and institute a 3% excise tax on cannabis products.

It’s important to note that the decision to reschedule marijuana is based on the Controlled Substances Act. The Drug Enforcement Administration (DEA) has the authority to make these decisions. Moreover, the federal appeals court reinstated a case filed against the federal government over the CSA. This case will allow the new Congress to take action and finally put an end to the criminalization of marijuana.

The first hearing has been scheduled by the House Health and Human Services Committee. There will be a briefing on the new Congress’s plans for marijuana regulation. In the short term, the CSA will evaluate petitions filed by the plaintiffs. If the drug has been re-scheduled, the DEA will consider this decision. If this happens, the FDA may decide to de-schedule marijuana. It’s unclear whether the DEA will reschedule cannabis at this time.

The DEA has a sweeping plan to defund the police. The new legislation could be a major step in legalizing marijuana, but the government should be aware of the risks involved in legalizing it. The United States has not approved cannabis for medical use, but it has been illegal for recreational purposes. However, the marijuana industry has been largely controlled by wealthy white people and only four percent of cannabis businesses are owned by people of color.

Some Members of the committee are suing to change the federal government’s marijuana laws. The lawsuit was filed by Super Bowl champion Marvin Washington, U.S. Army veteran Jose Belen, and the Cannabis Cultural Association. The group argues that the CSA’s marijuana law is unfair and unjust, and that legalizing it is a step in the right direction for patients.

There is an overwhelming need for more research on cannabis and marijuana-related products. The NIDA and FDA have explained that current restrictions on marijuana research have made it difficult to find safe products and recognize harmful ones. Similarly, the increased rates of hospital visits due to psychosis and marijuana toxicity are a cause of the lack of research. The HHS Secretary of Health and Human Services is the key advocate of legalization of the drug.

The U.S. Department of Justice is also considering the issue. The 113th Congress used its regulatory powers to make cannabis legal in most states. The Consolidated and Further Continuing Appropriations Act of 2015 was the first major bill to prohibit marijuana and the use of funds for federal enforcement. Although the U.S. Senate has not passed a bill yet, there is an ongoing discussion.